bariatric surgery and glp 1 ESG vs. vs. GLP-1 Therapy: Where Do We Stand in 2025? Bariatric Surgery in the GLP-1

The authors discuss the preclinical literature and emerging clinical evidence that support the rationale for investigating the use of glucagon-like peptide-1 receptor agonists to prevent and treat several neurodegenerative diseases of aging, with a focus on Alzheimers disease.

Off-label usage of GLP-1 weight loss drugs stacked with steroids for quick fat loss with minimal muscle wastage is a serious health concern

Wondering why semaglutide can make you tired

Compare 17 GLP-1 weight loss doctors and clinics in Seattle, Washington

95% CI 1.112.78), clinicians have remained cautious

But how do they compare for the unique needs of GLP-1 users